Vanguard Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$62.4B Buy
53,921,209
+392,341
+0.7% +$463M 1.31% 12
2026
Q2
$64.2B Buy
53,528,868
+167,094
+0.3% +$171M 1.37% 11
2026
Q1
$49.1B Buy
+53,361,774
New +$54.1B 1.21% 11

Other funds holding LLY

Vanguard Capital Management's LLY Position: Q3 2026 in Review

Vanguard Capital Management increased its Eli Lilly (LLY) stake by 0.73% in Q3 2026, buying an estimated $463M and bringing the position to 53,921,209 shares worth $62.4B. The position accounts for 1.31% of the portfolio, ranked #12.

Vanguard Capital Management first reported a position in LLY in Q1 2026 and has held it in 3 quarters since. The position peaked at $64.2B in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Vanguard Capital Management held 53,921,209 shares of Eli Lilly worth $62.4B as of Q3 2026.
  • Vanguard Capital Management bought 392,341 Eli Lilly shares in Q3 2026, an estimated $463M.
  • Eli Lilly made up 1.31% of Vanguard Capital Management's portfolio in Q3 2026, its #12 holding.
  • Vanguard Capital Management first reported a position in Eli Lilly in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Eli Lilly position peaked at $64.2B in Q2 2026.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.